QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information, visit our website at www.qltinc.com.
View Top Employees from QLT Inc.Website | http://www.qltinc.com |
Revenue | $138.4 million |
Employees | 95 (57 on RocketReach) |
Founded | 1981 |
Address | Suite 101, 887 Great Northern Way, Vancouver, British Columbia V5T 4T5, CA |
Phone | (877) 764-3131 |
Fax | (604) 707-7001 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325412 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular QLT Inc. employee's phone or email?
The QLT Inc. annual revenue was $138.4 million in 2024.
Stephen Bone is the CEO of QLT Inc..
57 people are employed at QLT Inc..
QLT Inc. is based in Vancouver, British Columbia.
The NAICS codes for QLT Inc. are [325412, 3254, 32, 32541, 325].
The SIC codes for QLT Inc. are [283, 28].